The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice

M. G. Murer, G. Dziewczapolski, P. Salin, M. Vila, K. Y. Tseng, M. Ruberg, M. Rubinstein, M. A. Kelly, David Grandy, M. J. Low, E. Hirsch, R. Raisman-Vozari, O. Gershanik

    Research output: Contribution to journalArticle

    23 Citations (Scopus)

    Abstract

    Recent pathophysiological models of basal ganglia function in Parkinson's disease predict that specific neurochemical changes in the indirect pathway would follow the lack of stimulation of D2 dopamine receptors. Post mortem studies of the basal ganglia in genetically modified mice lacking functional copies of the D2 dopamine receptor gene allowed us to test these predictions. When compared with their congenic N5 wild-type siblings, mice lacking D2 receptors show an increased expression of enkephalin messenger RNA in the striatum, and an increased activity and expression of cytochrome oxidase I in the subthalamic nucleus, as expected. In addition, D2 receptor-deficient mice display a reduced expression of glutamate decarboxylase-67 messenger RNA in the globus pallidus, as the basal ganglia model predicts. This reduction contrasts with the lack of change or increase in glutamate decarboxylase-67 messenger RNA expression found in animals depleted of dopamine after lesions of the mesostriatal dopaminergic system. Furthermore, D2 receptor-deficient mice show a significant decrease in substance P messenger RNA expression in the striatonigral neurons which form the direct pathway. Finally, glutamate decarboxylase-67 messenger RNA expression in the basal ganglia output nuclei was not affected by mutations in the D2 receptor gene, a fact that could probably be related to the absence of a parkinsonian locomotor phenotype in D2 receptor-deficient mice. In summary, these findings provide compelling evidence demonstrating that the lack of endogenous stimulation of D2 receptors is sufficient to produce subthalamic nucleus hyperactivity, as assessed by cytochrome oxidase I histochemistry and messenger RNA expression, and strongly suggest the existence of interactions between the basal ganglia direct and indirect pathways. (C) 2000 IBRO.

    Original languageEnglish (US)
    Pages (from-to)643-650
    Number of pages8
    JournalNeuroscience
    Volume99
    Issue number4
    DOIs
    StatePublished - Aug 23 2000

    Fingerprint

    Basal Ganglia
    Messenger RNA
    Glutamate Decarboxylase
    Subthalamic Nucleus
    Dopamine D2 Receptors
    Electron Transport Complex IV
    Globus Pallidus
    Enkephalins
    Substance P
    Genes
    Parkinson Disease
    mouse DRD2 protein
    Dopamine
    Phenotype
    Neurons
    Mutation

    Keywords

    • Globus pallidus
    • Parkinson's disease
    • Striatum
    • Substantia nigra
    • Subthalamic nucleus

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Murer, M. G., Dziewczapolski, G., Salin, P., Vila, M., Tseng, K. Y., Ruberg, M., ... Gershanik, O. (2000). The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice. Neuroscience, 99(4), 643-650. https://doi.org/10.1016/S0306-4522(00)00223-2

    The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice. / Murer, M. G.; Dziewczapolski, G.; Salin, P.; Vila, M.; Tseng, K. Y.; Ruberg, M.; Rubinstein, M.; Kelly, M. A.; Grandy, David; Low, M. J.; Hirsch, E.; Raisman-Vozari, R.; Gershanik, O.

    In: Neuroscience, Vol. 99, No. 4, 23.08.2000, p. 643-650.

    Research output: Contribution to journalArticle

    Murer, MG, Dziewczapolski, G, Salin, P, Vila, M, Tseng, KY, Ruberg, M, Rubinstein, M, Kelly, MA, Grandy, D, Low, MJ, Hirsch, E, Raisman-Vozari, R & Gershanik, O 2000, 'The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice', Neuroscience, vol. 99, no. 4, pp. 643-650. https://doi.org/10.1016/S0306-4522(00)00223-2
    Murer MG, Dziewczapolski G, Salin P, Vila M, Tseng KY, Ruberg M et al. The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice. Neuroscience. 2000 Aug 23;99(4):643-650. https://doi.org/10.1016/S0306-4522(00)00223-2
    Murer, M. G. ; Dziewczapolski, G. ; Salin, P. ; Vila, M. ; Tseng, K. Y. ; Ruberg, M. ; Rubinstein, M. ; Kelly, M. A. ; Grandy, David ; Low, M. J. ; Hirsch, E. ; Raisman-Vozari, R. ; Gershanik, O. / The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice. In: Neuroscience. 2000 ; Vol. 99, No. 4. pp. 643-650.
    @article{4774c5d796ec4ec0a109702815fae11c,
    title = "The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice",
    abstract = "Recent pathophysiological models of basal ganglia function in Parkinson's disease predict that specific neurochemical changes in the indirect pathway would follow the lack of stimulation of D2 dopamine receptors. Post mortem studies of the basal ganglia in genetically modified mice lacking functional copies of the D2 dopamine receptor gene allowed us to test these predictions. When compared with their congenic N5 wild-type siblings, mice lacking D2 receptors show an increased expression of enkephalin messenger RNA in the striatum, and an increased activity and expression of cytochrome oxidase I in the subthalamic nucleus, as expected. In addition, D2 receptor-deficient mice display a reduced expression of glutamate decarboxylase-67 messenger RNA in the globus pallidus, as the basal ganglia model predicts. This reduction contrasts with the lack of change or increase in glutamate decarboxylase-67 messenger RNA expression found in animals depleted of dopamine after lesions of the mesostriatal dopaminergic system. Furthermore, D2 receptor-deficient mice show a significant decrease in substance P messenger RNA expression in the striatonigral neurons which form the direct pathway. Finally, glutamate decarboxylase-67 messenger RNA expression in the basal ganglia output nuclei was not affected by mutations in the D2 receptor gene, a fact that could probably be related to the absence of a parkinsonian locomotor phenotype in D2 receptor-deficient mice. In summary, these findings provide compelling evidence demonstrating that the lack of endogenous stimulation of D2 receptors is sufficient to produce subthalamic nucleus hyperactivity, as assessed by cytochrome oxidase I histochemistry and messenger RNA expression, and strongly suggest the existence of interactions between the basal ganglia direct and indirect pathways. (C) 2000 IBRO.",
    keywords = "Globus pallidus, Parkinson's disease, Striatum, Substantia nigra, Subthalamic nucleus",
    author = "Murer, {M. G.} and G. Dziewczapolski and P. Salin and M. Vila and Tseng, {K. Y.} and M. Ruberg and M. Rubinstein and Kelly, {M. A.} and David Grandy and Low, {M. J.} and E. Hirsch and R. Raisman-Vozari and O. Gershanik",
    year = "2000",
    month = "8",
    day = "23",
    doi = "10.1016/S0306-4522(00)00223-2",
    language = "English (US)",
    volume = "99",
    pages = "643--650",
    journal = "Neuroscience",
    issn = "0306-4522",
    publisher = "Elsevier Limited",
    number = "4",

    }

    TY - JOUR

    T1 - The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice

    AU - Murer, M. G.

    AU - Dziewczapolski, G.

    AU - Salin, P.

    AU - Vila, M.

    AU - Tseng, K. Y.

    AU - Ruberg, M.

    AU - Rubinstein, M.

    AU - Kelly, M. A.

    AU - Grandy, David

    AU - Low, M. J.

    AU - Hirsch, E.

    AU - Raisman-Vozari, R.

    AU - Gershanik, O.

    PY - 2000/8/23

    Y1 - 2000/8/23

    N2 - Recent pathophysiological models of basal ganglia function in Parkinson's disease predict that specific neurochemical changes in the indirect pathway would follow the lack of stimulation of D2 dopamine receptors. Post mortem studies of the basal ganglia in genetically modified mice lacking functional copies of the D2 dopamine receptor gene allowed us to test these predictions. When compared with their congenic N5 wild-type siblings, mice lacking D2 receptors show an increased expression of enkephalin messenger RNA in the striatum, and an increased activity and expression of cytochrome oxidase I in the subthalamic nucleus, as expected. In addition, D2 receptor-deficient mice display a reduced expression of glutamate decarboxylase-67 messenger RNA in the globus pallidus, as the basal ganglia model predicts. This reduction contrasts with the lack of change or increase in glutamate decarboxylase-67 messenger RNA expression found in animals depleted of dopamine after lesions of the mesostriatal dopaminergic system. Furthermore, D2 receptor-deficient mice show a significant decrease in substance P messenger RNA expression in the striatonigral neurons which form the direct pathway. Finally, glutamate decarboxylase-67 messenger RNA expression in the basal ganglia output nuclei was not affected by mutations in the D2 receptor gene, a fact that could probably be related to the absence of a parkinsonian locomotor phenotype in D2 receptor-deficient mice. In summary, these findings provide compelling evidence demonstrating that the lack of endogenous stimulation of D2 receptors is sufficient to produce subthalamic nucleus hyperactivity, as assessed by cytochrome oxidase I histochemistry and messenger RNA expression, and strongly suggest the existence of interactions between the basal ganglia direct and indirect pathways. (C) 2000 IBRO.

    AB - Recent pathophysiological models of basal ganglia function in Parkinson's disease predict that specific neurochemical changes in the indirect pathway would follow the lack of stimulation of D2 dopamine receptors. Post mortem studies of the basal ganglia in genetically modified mice lacking functional copies of the D2 dopamine receptor gene allowed us to test these predictions. When compared with their congenic N5 wild-type siblings, mice lacking D2 receptors show an increased expression of enkephalin messenger RNA in the striatum, and an increased activity and expression of cytochrome oxidase I in the subthalamic nucleus, as expected. In addition, D2 receptor-deficient mice display a reduced expression of glutamate decarboxylase-67 messenger RNA in the globus pallidus, as the basal ganglia model predicts. This reduction contrasts with the lack of change or increase in glutamate decarboxylase-67 messenger RNA expression found in animals depleted of dopamine after lesions of the mesostriatal dopaminergic system. Furthermore, D2 receptor-deficient mice show a significant decrease in substance P messenger RNA expression in the striatonigral neurons which form the direct pathway. Finally, glutamate decarboxylase-67 messenger RNA expression in the basal ganglia output nuclei was not affected by mutations in the D2 receptor gene, a fact that could probably be related to the absence of a parkinsonian locomotor phenotype in D2 receptor-deficient mice. In summary, these findings provide compelling evidence demonstrating that the lack of endogenous stimulation of D2 receptors is sufficient to produce subthalamic nucleus hyperactivity, as assessed by cytochrome oxidase I histochemistry and messenger RNA expression, and strongly suggest the existence of interactions between the basal ganglia direct and indirect pathways. (C) 2000 IBRO.

    KW - Globus pallidus

    KW - Parkinson's disease

    KW - Striatum

    KW - Substantia nigra

    KW - Subthalamic nucleus

    UR - http://www.scopus.com/inward/record.url?scp=0034706071&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0034706071&partnerID=8YFLogxK

    U2 - 10.1016/S0306-4522(00)00223-2

    DO - 10.1016/S0306-4522(00)00223-2

    M3 - Article

    C2 - 10974427

    AN - SCOPUS:0034706071

    VL - 99

    SP - 643

    EP - 650

    JO - Neuroscience

    JF - Neuroscience

    SN - 0306-4522

    IS - 4

    ER -